116 related articles for article (PubMed ID: 30179909)
1. 18F-Fluoride Uptake in Soft Tissue Metastases of Medullary Thyroid Carcinoma as a Marker of Progressive Calcification.
Duarte PS; Marin JFG; Filho GBC; Sapienza MT; Buchpiguel CA
Clin Nucl Med; 2018 Nov; 43(11):848-849. PubMed ID: 30179909
[TBL] [Abstract][Full Text] [Related]
2. Visualization of Lymph Nodal and Hepatic Metastases of Medullary Thyroid Carcinoma on 18F-Fluoride PET/CT.
do Vale RH; Marin JF; Duarte PS; Sapienza MT; Buchpiguel CA
Clin Nucl Med; 2015 Nov; 40(11):895-6. PubMed ID: 26444649
[TBL] [Abstract][Full Text] [Related]
3. Correlation of
Ueda CE; Flausino Dias L; de Godoi Carneiro C; Sapienza MT; Alberto Buchpiguel C; Schiavom Duarte P
Arch Endocrinol Metab; 2024 Apr; 68():e230152. PubMed ID: 38602746
[TBL] [Abstract][Full Text] [Related]
4. Brain Metastasis of Medullary Thyroid Carcinoma Without Macroscopic Calcification Detected First on 68Ga-Dotatate and Then on 18F-Fluoride PET/CT.
Duarte PS; Marin JFG; De Carvalho JWA; Sapienza MT; Buchpiguel CA
Clin Nucl Med; 2018 Aug; 43(8):623-624. PubMed ID: 29894334
[TBL] [Abstract][Full Text] [Related]
5. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract][Full Text] [Related]
6. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
[TBL] [Abstract][Full Text] [Related]
7. (18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Archier A; Heimburger C; Guerin C; Morange I; Palazzo FF; Henry JF; Schneegans O; Mundler O; Abdullah AE; Sebag F; Imperiale A; Taïeb D
Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1027-33. PubMed ID: 26497699
[TBL] [Abstract][Full Text] [Related]
8. Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Okamoto M; Takazawa A; Aoki K; Yoshimura Y; Kato H; Otsuki T; Maeno K; Koizumi T
World J Surg Oncol; 2017 Dec; 15(1):221. PubMed ID: 29237502
[TBL] [Abstract][Full Text] [Related]
9. Unsuspected Metastases to Muscles in Osteosarcoma Detected on 18F-Sodium Fluoride PET-CT.
Usmani S; Marafi F; Rasheed R; Bakiratharajan D; Al Maraghy M; Al Kandari F
Clin Nucl Med; 2018 Sep; 43(9):e343-e345. PubMed ID: 30080191
[TBL] [Abstract][Full Text] [Related]
10. Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer.
Ueda CE; Duarte PS; de Castroneves LA; Flávio J; Marin G; Sado HN; Sapienza MT; Hoff AO; Buchpiguel CA
Nucl Med Commun; 2020 May; 41(5):469-476. PubMed ID: 32187160
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
Caobelli F; Chiaravalloti A; Evangelista L; Saladini G; Schillaci O; Vadrucci M; Scalorbi F; Donner D; Alongi P;
Ann Nucl Med; 2018 Jan; 32(1):7-15. PubMed ID: 28986764
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography Imaging in Medullary Thyroid Carcinoma: Time for Reappraisal?
Castinetti F; Taïeb D
Thyroid; 2021 Feb; 31(2):151-155. PubMed ID: 33191866
[TBL] [Abstract][Full Text] [Related]
13. [Medullary carcinoma of the thyroid with calcified metastases].
Hörmann M; Hackl A; Schneider G
Rofo; 1985 Jul; 143(1):118-20. PubMed ID: 2992005
[No Abstract] [Full Text] [Related]
14. 18F-FDG PET Detection of a Medullary Thyroid Carcinoma in a Patient With SMZL.
Paschali A; Moonim M; Hubbard J; Mohan H
Clin Nucl Med; 2016 Oct; 41(10):e447-8. PubMed ID: 27355850
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of PET/CT with
Romero-Lluch AR; Cuenca-Cuenca JI; Guerrero-Vázquez R; Martínez-Ortega AJ; Tirado-Hospital JL; Borrego-Dorado I; Navarro-González E
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2004-2013. PubMed ID: 28646462
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
Guo HH; Moradi F; Iagaru A
Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100
[TBL] [Abstract][Full Text] [Related]
17. High frequency ultrasound features and pathological characteristics of medullary thyroid carcinoma.
Wang H; Liu M; Yang J; Song Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2269-2271. PubMed ID: 28167464
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
Thyroid; 2010 May; 20(5):527-33. PubMed ID: 20450432
[TBL] [Abstract][Full Text] [Related]
19. Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on
Duarte PS; de Castroneves LA; Sado HN; Sapienza MT; de Oliveira Hoff AAF; Buchpiguel CA
Nucl Med Mol Imaging; 2018 Aug; 52(4):318-323. PubMed ID: 30100945
[TBL] [Abstract][Full Text] [Related]
20. The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Golubić AT; Pasini Nemir E; Žuvić M; Mutvar A; Kusačić Kuna S; Despot M; Samardžić T; Huić D
Nucl Med Commun; 2017 Jul; 38(7):636-641. PubMed ID: 28562377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
